Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0UVJLX)
| ADC Name |
CN118924912A anti-HER2 ADC20
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
anti-HER2 ADC20
Click to Show/Hide
|
|||||
| Organization |
NOVACYTE THERAPEUTICS CO., LTD
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.1
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
CN118924912A anti-HER2 ADC20 Payload
|
Payload Info | ||||
| Linker Name |
CN118924912A anti-HER2 ADC1 Linker
|
Linker Info | ||||
| Conjugate Type |
Cysteine-maleimide conjugation
|
|||||
| Combination Type |
DL-20
|
|||||